BioPredictive has a wide variety of non-invasive diagnostic tests for liver disease at its disposal.
Each of our tests is designed with the same philosophy and the same rigor in order to offer a high-quality service with complete safety and confidence.
These easy-to-implement tests involve taking a blood sample and result in an user-friendly, illustrated results sheet.
It estimates the extent of hepatic steatosis (fatty liver deposits), which is a frequent cause of high Gamma-GT and transaminase levels.
Find out more
Estimates non-alcoholic steatohepatitis (NASH) severity in insulin-resistant, overweight, diabetic, or hyperlipidemic patients.
Find out more
Estimates the level of alcoholic steato-hepatitis (ASH) in patients who consume excess volumes of alcohol
Find out more« FibroTest is more effective and less costly than liver biopsy. »
Liu S et al, Plos One 2011 1
BioPredictive's diagnostic tests are grouped into two ranges:
FibroTest-ActiTest, indicated in the viral hepatitis B and C ;
NASH-FibroTest, indicated in subjects at risk of NAFLD (Non-Alcoholic Fatty Liver Disease) with or without comorbidity (Alcohol and hepatitis);
Since 2021, the FibroMax is replaced by the NASH-FibroTest. It was used in subjects presenting with metabolic conditions: alcohol, excess weight, arterial hypertension, diabetes, abnormal triglyceride or cholesterol levels.
FibroTest-ActiTest |
NASH-FibroTest |
FibroMax |
|
|---|---|---|---|
| FibroTest | |||
| ActiTest | |||
| SteatoTest 2 | |||
| NashTest 2 | |||
| AshTest | |||
| Requires empty stomach? | No | Yes | Yes |
| Requires BMI?(height and weight of patient) | No | No | Yes |
| SAF scoring? | |||
| CRN scoring? | |||
| Learn more | Learn more | Learn more |
BioPredictive is an independent bio-pharmaceutical company, based in France, which designs and markets diagnostic tests for liver diseases, in particular FibroTest and NASH-FibroTest.
Contact us Twitter FaceBook
